Hospital Pharmacy Automation Case Study: Dispensing Risk Fell to 0.84

Why the Central Pharmacy Needed Tighter Control

The pharmacy was handling a larger and more complex medication flow by the post-automation period. Inpatients rose from 18,830 in 2013 to 24,491 in 2017, beds grew from 369 to 469, and medications dispensed climbed from 3,245,051 to 4,796,341.

That scale changes how a hospital should judge performance. Raw error counts can rise simply because more medication is moving, so the real question is where errors occur, how often items are returned, and how much waste shows up through breakages, losses, and expired stock.

• Higher inpatient volume and bed capacity increased dispensing complexity
• The central pharmacy needed tighter control over returned items and medication waste
• The operation had to improve dispensing safety without losing traceability across the workflow

A Staged Automation Rollout in the Central Pharmacy

The hospital did not switch everything at once. The paper describes a phased path: electronic dispensing support began in 2011, decentralized electronic dispensaries were added in 2013, and central pharmacy automation went live in 2014.

Inside the central pharmacy, the automated setup handled both unit-dose and non-unit-dose medication. The system added medication unitization, sequential traceability for each unit dispensed, daily stock inventory, protection against expired medication, and a more centralized dispensing process.

The study also surfaces a practical rollout lesson. When late deliveries increased after automation, the authors linked that result to rule definition and training gaps in medication administration scheduling, which shows that equipment, workflow design, and staff training have to move together.

• Phase 1: electronic dispensing support
• Phase 2: decentralized dispensaries for faster urgent access
• Phase 3: central pharmacy automation with traceability and daily inventory control

What Changed After Automation

The headline result sits in the dispensing phase itself. Reported medication errors rose in absolute count from 637 to 871 as volume expanded, but the overall error rate stayed essentially flat at 0.019% before automation and 0.018% after, while the relative risk for dispensing-phase errors fell to 0.84 with a 95% confidence interval of 0.70 to 0.99.

The quality gains extended beyond error risk. Returned items fell from 45,146 to 41,548, and breakages and losses in dispensed batches dropped from 15,085, or 0.46%, to 4,624, or 0.10%, a reported relative risk of 0.21. The authors also report fewer expired drugs and products after automation.

Severity shifted in a favorable direction inside the dispensing phase. No-harm events rose from 87% to 92% of reported errors in that phase, while severe events fell from 10 to 1. This was not a pure speed story, though. Delays in drug delivery per month increased from 195 to 283, and the authors explicitly note more late batches after automation.

What This Means for US Hospital Pharmacy Buyers

This study is not a Service Robot Co. deployment. It is a documented real-world example of what pharmacy automation can do when the objective is tighter dispensing control, better traceability, and lower waste, not just a faster stopwatch.

That is where Service Robot Co. becomes relevant as a vendor neutral robot integrator. For US operators, the hard part is rarely the machine alone. It is robot deployment and integration, phased deployment no shutdown, staff training, and maintenance included after go-live, with lease rental or sale and monthly payment programs when no upfront capital is preferred.

The paper also shows why one partner one number matters. Automation improved dispensing quality and inventory control, but delivery timing still depended on rules, scheduling discipline, and frontline adoption. Service Robot Co. wraps planning, training, remote triage, on-site dispatch, and lifecycle support around a nationwide US engineer network so those handoffs do not get scattered across separate vendors.